Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Osteoporosis medicine lowers breast cancer relapse rate

Photo: APA (dpa) © Photo: APA (dpa)

"The results are spectacular“, said lead investigator Michael Gnant, Head of the University Department of Surgery at the Medical University of Vienna at Vienna’s General Hospital, President of the Austrian Breast & Colorectal Cancer Study Group (ABCSG) and Deputy Head of the Comprehensive Cancer Center (CCC; Medical University of Vienna/Vienna General Hospital). 65 treatment centers throughout Austria with a total of 3,425 postmenopausal breast cancer patients took part in the study.

Several years ago, it was already demonstrated that osteoporosis drugs from the class of bisphosphonates can prevent a good percentage of therapy-related bone atrophy. At the same time, use of these drugs can also reduce the rate of recurrence for mammary carcinoma patients.

A meta-analysis of existing data (“The Lancet“) published by Gnant and other authors in July 2015 after a large scale study clearly demonstrated this additional effect. The frequency of bone fractures was reduced by 50 percent. The bone density enhancing anti-osteoporosis therapy led to a 28 percent reduction in bone metastases and an 18 percent decline in the long-term breast cancer mortality rate.     

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Expand to Austria

    26.06.2019, Brescia, Italy

  • Research Dialogue with Summery Jazz Sounds

    02.07.2019, Stuttgart, Germany

Austria Map

Find the perfect location for your company

A country like Austria considered to be an especially good terrain for upscale industrial segments, and with a particular emphasis on research and environmental friendliness, represents a major opportunity for SIAD. Our corporate goal is namely to assist the customer and provide support in improving the productivity and the environmental compatibility of its work processes.

SIAD

SIAD
More testimonials

news from the business location Austria

Ottobock invests EUR 2 million in Vienna

The underlying basis of success of the globally recognised development work of the German life sciences company Ottobock being carried out in Vienna is the extremely pronounced medical research landscape offering fertile ground for interdisciplinary R&D projects.

Innovations from Austria for the Logistics Sector

At the present time there are many influencing factors which pose challenges to the supply chain and logistics management. Solutions in this area are frequently developed by startups, also from Austria. Several of them will present their innovations at the Austrian Logistics Day and Logistics Future Lab.

More news All blog posts